Globe Life Inc.
GL - NYSE - $151.08 ▼ -%0.90
-
Earnings
Wed 22 Jul
Globe opens the
books on Wednesday evening.
2 analysts' median target is $172[FMP target], stock is $151, +13.5% upside potential. After Q1 +-0.9% EPS beat[FMP earnings], the stock moved +1.8%.
↓
summary below
Quick Take - in 40 seconds
A
HOLD
Council 3/6
-
Moonshot 53
A = MoonshotScore 53[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].
Q4 consensus: revenue $1.6B[FMP est], EPS $3.68[FMP est]. 0 consecutive quarters of beat[FMP earnings].
$3.68
EPS Estimate
Last year $3.39 - +13% YoY YoY
-
American Income Life Guidance
Previous quarter was 0%
0
Beat Streak
Expectations beaten consecutively for the last 0 quarters
Q1 EPS +-0.9% beat[FMP] but the stock +1.8% D+1[FMP D+1]. Tom Kalmbach promised $24.9M CapEx + a sequential decline in Q4 during the Q1 earnings call[Tom Kalmbach capex transcript].
Health Premium Growth Guidance
health_premium_growth_guidance
Globe Life expects health premium revenue to grow in the range of 14% to 17% for the year.
"For the year, we expect health premium revenue to grow in the range of 14% to 17%."
- Frank Svoboda - Q1 FY26 Earnings Call - April 23, 2026
Life Premium Growth Guidance
life_premium_growth_guidance
Globe Life expects life premium revenue to grow between 3% and 3.5% for the year 2026.
"For the year, we expect life premium revenue to grow between 3% and 3.5%."
- Frank Svoboda - Q1 FY26 Earnings Call - April 23, 2026
Premium Revenue Growth Guidance
premium_revenue_growth_guidance
Globe Life expects total premium revenue to grow approximately 7% for the full year 2026.
"For the full year, we expect total premium revenue to grow approximately 7%."
- Frank Svoboda - Q1 FY26 Earnings Call - April 23, 2026
$560 million
Investor Focus
Share Repurchase Increase
share_repurchase_increase
Globe Life has increased the range for anticipated share repurchases to $560 million to $610 million for the full year 2026.
"In addition, we have increased the range for anticipated share repurchases to $560 million to $610 million for the full year."
- Thomas Kalmbach - Q1 FY26 Earnings Call - April 23, 2026
Stock Expert AI - Methodology
Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?
MoonshotScore
53 / 100
9-pillar methodology. Cash Runway and Price Momentum strong. Revenue Growth weak.
How is it calculated? ->
Revenue Growth3.0
Q1 vs Q2: moderate growth (+5.3%)
Gross Margin5.0
Q1: average margin (49.4%)
Operating Leverage2.0
op margin healthy (23.6%)
Cash Runway10.0
FCF very strong ($0.4B, 15.9x CapEx)
R&D Intensity3.0
low R&D investment (0.0%, weak innovation)
Price Momentum7.0
RSI 54.0 balanced, 50d above
News Sentiment7.0
strong buy consensus (73%)
Council Score
3 / 6 Bullish
6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).
How is it calculated? ->
Ray Dalio macro - target upside +13.5%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 54
Klarman value - target upside +13.5%
Buffett quality - ROE score 5/5
Munger valuation - target upside +13.5%
Munger's Mindset character & balance sheet lens
Fairly Valued
Quality business, trading at fair value.
How is it calculated? ->
Interest CoverageAdequate
Technical Levels - Pre-earnings positioning
What levels is the stock being tested at?
RSI(14)
54.0
RSI 54.0 balanced, 50d above
MACD
+3.90
price above 50d - support positive
50d MA
$145
stock 3.9% above - short-term support
200d MA
$140
stock 7.7% above - long-term support
Volume (10d)
-10%
decrease - low participation
Resistance
$172
Analyst median target - upgrade trigger if broken
Current
$151
Pre-earnings position
Support
$119
Invalidation - close below this is a technical breakdown
Pattern
Range
$119-$172 band - earnings breakout/breakdown trigger
Past Performance
Globe's last 8 quarters: 0 consecutive beats.
BEAT
Q2 FY25
$3.27 vs $3.25 est - +5.4%
BEAT
Q3 FY25
$4.81 vs $4.60 est - +0.1%
MISS
Q4 FY25
$3.39 vs $3.44 est - +1.5%
MISS
Q1 FY26
$3.43 vs $3.46 est - +1.8%
Q1 (April 23, 2026): EPS $3.43 vs $3.46 est[FMP], +-0.9% beat. D+1 movement: +1.8%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.
Three scenarios: what could happen?
EPS < $3.57 (no guidance)
Q1: EPS $3.43 vs $3.46 beat[FMP], stock +1.8% D+1[FMP].
"-"
- Tom Kalmbach, CFO - Q1 FY26 Earnings Call - April 23, 2026
Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.
Insider trading signal
Form 4 data is marked in the table - this page does not generate assumptions for this stock.
Our FMP plan does not provide Form 4 insider feed for this stock. This page does not generate assumptions - SEC EDGAR Form 4 can be monitored directly.
CapEx shock
Q1 CapEx $24.9M[FMP cashflow]. Q1 op margin 23.6%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.
"-"
- Tom Kalmbach, CFO - Q1 FY26 Earnings Call - April 23, 2026
Framework - Position discipline
After the data arrives: 3 scenarios, 3 windows
Not advice - a structural framework for earnings night. Decision discipline is yours.
Scenario A - Beat
Q4 EPS > $3.68 + CapEx discipline
Threshold: EPS > $3.68[FMP est].
Target: Break above median target $172[FMP target]; high target $185[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.68 + CapEx < $24.9M
Threshold: EPS approx $3.68[FMP est], Q4 CapEx < $24.9M[FMP].
Target: Consolidation in the band between current $151[FMP] and median $172[FMP].
Scenario C - Miss
EPS < $3.57 or CapEx >= $24.9M
Threshold: EPS < $3.57[FMP estx0.97].
Target: Current $151 below SMA200 $140[FMP], if rejection continues, $119[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.
Market Outlook
What do 2 analysts say?
Wall Street Consensus
$172
12-month median target price (+13.5% upside potential)
Risk Management
$119
Invalidation level - critical support threshold
$145 - 50-day MA (above, +3.9%)
$140 - 200-day MA (above, +7.7%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - GL Q4 FY26
A
You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Wednesday evening. The framework is ready on this page: Q4 EPS threshold $3.68[FMP], CapEx threshold "below $24.9M"[Tom Kalmbach]. Two anchors, three scenarios.
Comparison
Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).
3 subscriptions. 1 platform.
Seeking Alpha $299/yr - analyst opinions + earnings coverage
TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades
Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
Catalyst Calendar - 90-day forward look
Jul 22, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 23, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 5, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 22, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
Frequently Asked Questions
What does the GL earnings preview cover?
This GL (GL) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
What should investors watch for in GL earnings?
Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.